Literature DB >> 14585395

Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting.

Hajime Takikawa1, Yoriyuki Takamori, Teru Kumagi, Morikazu Onji, Masaaki Watanabe, Akitaka Shibuya, Akiko Hisamochi, Ryukichi Kumashiro, Tadashi Ito, Yasuhide Mitsumoto, Atsushi Nakamura, Takashi Sakaguchi.   

Abstract

Two hundred and eighty seven Japanese cases of drug induced liver injury were assessed by the diagnostic scale of the International Consensus Meeting (ICM). They were classified to the hepatocellular (55%), mixed (24%) and cholestatic (22%) type according to the type of liver injury. Five cases were diagnosed as 'unrelated', since the reaction occurred more than 15 days after stopping the drug. The remaining 282 cases were classified to 69 cases of 'highly probable', 170 cases of 'probable', 39 cases of 'possible', and four cases of 'unlikely'. The cases with positive drug-lymphocyte stimulation test (DLST) and with eosinophilia distributed to higher scores. Although the diagnostic scale of the ICM was found to be also useful for Japanese cases, the modification of the scale including the data of DLST and eosinophilia together with some other modifications were recommended in the view of the present status of Japan. Using the modified diagnostic scale, the 287 cases were classified to 173 cases of 'highly probable', 102 cases of "probable', 11 cases of 'possible', and one case of 'unlikely'. Although the modified diagnostic scale seems better than the original one, further assessment of the modified scale using many Japanese cases is needed for the further improvement of the scale.

Entities:  

Year:  2003        PMID: 14585395     DOI: 10.1016/s1386-6346(03)00232-8

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  24 in total

1.  Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.

Authors:  Saibal Das; Sapan K Behera; Alphienes S Xavier; Srinivas Velupula; Steven A Dkhar; Sandhiya Selvarajan
Journal:  Clin Drug Investig       Date:  2018-03       Impact factor: 2.859

2.  Safe administration of rituximab for follicular lymphoma after obinutuzumab infusion-related reaction.

Authors:  Takeshi Hara; Ryohei Suzuki; Akihisa Ohno; Kengo Yamakawa; Yasumasa Yamagishi; Yoshihiro Sugiyama; Takuya Sobajima; Rie Yamada; Rie Matsumoto; Yoko Ikeda; Masanori Murayama; Hisashi Tsurumi
Journal:  Int J Hematol       Date:  2019-12-17       Impact factor: 2.490

3.  Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice.

Authors:  William R Proctor; Mala Chakraborty; Lynette S Chea; Jeffrey C Morrison; Julia D Berkson; Kenrick Semple; Mohammed Bourdi; Lance R Pohl
Journal:  Hepatology       Date:  2013-03-15       Impact factor: 17.425

4.  Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop.

Authors:  Robert J Fontana; Leonard B Seeff; Raúl J Andrade; Einar Björnsson; Christopher P Day; Jose Serrano; Jay H Hoofnagle
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

Review 5.  Tools for causality assessment in drug-induced liver disease.

Authors:  Hans L Tillmann; Ayako Suzuki; Huiman X Barnhart; Jose Serrano; Don C Rockey
Journal:  Curr Opin Gastroenterol       Date:  2019-05       Impact factor: 3.287

Review 6.  Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.

Authors:  Rolf Teschke; Albrecht Wolff; Christian Frenzel; Alexander Schwarzenboeck; Johannes Schulze; Axel Eickhoff
Journal:  World J Hepatol       Date:  2014-01-27

Review 7.  Practical guidelines for diagnosis and early management of drug-induced liver injury.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

Review 8.  Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods.

Authors:  Rolf Teschke; Christian Frenzel; Johannes Schulze; Axel Eickhoff
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

9.  Novel Approaches to Causality Adjudication in Drug-Induced Liver Disease.

Authors:  Hans L Tillmann; Huiman X Barnhart; Jose Serrano; Don C Rockey
Journal:  Curr Hepatol Rep       Date:  2018-07-11

Review 10.  Drug-induced liver injury: present and future.

Authors:  Ki Tae Suk; Dong Joon Kim
Journal:  Clin Mol Hepatol       Date:  2012-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.